POTELIGEO

This brand name is authorized in Austria, Estonia, Spain, Finland, France, Ireland, Israel, Japan, Lithuania, Poland, Romania, United Kingdom, United States

Active ingredients

The drug POTELIGEO contains one active pharmaceutical ingredient (API):

1 Mogamulizumab
UNII YI437801BE - MOGAMULIZUMAB

Mogamulizumab is a defucosylated, humanised IgG1 kappa immunoglobulin that selectively binds to CCR4, a G protein-coupled receptor for CC chemokines that is involved in the trafficking of lymphocytes to various organs including the skin, resulting in depletion of the target cells.

Read about Mogamulizumab

Medication package inserts

Below package inserts are available for further reading:

Title Information Source Document Type  
POTELIGEO Concentrate for solution for infusion European Medicines Agency (EU) MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
L01FX09 Mogamulizumab L Antineoplastic and immunomodulating agents → L01 Antineoplastic agents → L01F Monoclonal antibodies and antibody drug conjugates → L01FX Other monoclonal antibodies
Discover more medicines within L01FX09

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: EE Ravimiamet Identifier(s): 1783638
Country: ES Centro de información online de medicamentos de la AEMPS Identifier(s): 1181335001
Country: FI Lääkealan turvallisuus- ja kehittämiskeskus Identifier(s): 533964
Country: FR Base de données publique des médicaments Identifier(s): 62292771
Country: GB Medicines & Healthcare Products Regulatory Agency Identifier(s): 382328
Country: IL מִשְׂרַד הַבְּרִיאוּת Identifier(s): 9342
Country: JP 医薬品医療機器総合機構 Identifier(s): 4291422A1021
Country: LT Valstybinė vaistų kontrolės tarnyba Identifier(s): 1086750
Country: PL Rejestru Produktów Leczniczych Identifier(s): 100416714
Country: RO Agenția Națională a Medicamentului și a Dispozitivelor Medicale Identifier(s): W67184001
Country: US FDA, National Drug Code Identifier(s): 42747-761

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.